Prognosis after a complete remission in adult patients with idiopathic membranous nephropathy

Prognosis after a complete remission in adult patients with idiopathic membranous nephropathy
复制标题

DOI:
10.1016/s0272-6386(99)70138-1
复制
发表时间:
1999-06-01
影响因子:
13.2
通讯作者:
Cattran, DC
Cattran, DC
中科院分区:
医学1区
文献类型:
--
作者:
Laluck, BJ;Cattran, DC

文献摘要

被引文献

相似文献

本研究回顾了82例经活检证实的特发性膜性肾小球肾炎(IMGN)成人患者在蛋白尿完全缓解后的长期结局,占我们登记研究中IMGN总病例的25%(323例中的82例)。完全缓解定义为至少连续两次随访评估显示蛋白尿0.3g/d或更少的蛋白。缓解前,70%的患者有肾病范围的蛋白尿(就诊时61%,随访期间9%),30%始终为亚肾病平均总观察时间为101 ± 56个月,缓解后时间为69 ± 60个月。71%的患者保持缓解,29%复发。在复发组中,46%复发至肾病范围蛋白尿,54%复发至亚肾病水平。86%的患者(82例患者中的71例)的血浆肌酐水平保持稳定,但在其余14%的患者(82例患者中的8例)中,尽管有一段时间的完全缓解,血浆肌酐水平仍升高或保持升高。没有患者继续发展为终末期肾病。77%的患者在缓解后6个月内没有接受过特异性治疗,而23%的患者接受了单独的类固醇治疗或与免疫抑制剂联合治疗。在多变量分析中,有利于缓解及其持久性的因素是持续较低水平的蛋白尿和女性。完全缓解表明IMGN患者的长期预后良好,但复发是常见的,并且在一小部分患者中发生慢性肾功能不全。因此,我们的数据表明,即使是这组患者也应该定期监测。(C)1999年由国家肾脏基金会,公司。
This review of the long-term outcome after a complete remission of proteinuria includes 82 adult patients with biopsy-proven idiopathic membranous glomerulonephritis (IMGN), who represented 25% of the total cases (82 of 323 cases) of IMGN in our registry. Complete remission was defined as at least two consecutive follow-up evaluations showing proteinuria of 0.3 g/d or less of protein, Before remission, 70% of the patients had nephrotic-range proteinuria (61% at presentation, 9% during follow-up), and 30% were always subnephrotic (protein level < 3.5 g/d), Mean total observation time was 101 +/- 56 months, with a postremission period of 69 +/- 60 months. Seventy-one percent of the patients remained in remission and 29% relapsed. In the relapse group, 46% relapsed to nephrotic-range proteinuria and 54% relapsed to subnephrotic levels. The plasma creatinine level remained stable in 86% of the patients (71 of 82 patients) but became or remained elevated despite a period of complete remission in the remaining 14% (8 of 82 patients). No patient went on to end-stage renal disease. Seventy-seven percent of the patients had no specific treatment within 6 months of remission, whereas 23% had steroid therapy alone or in combination with an immunosuppressive agent. In a multivariate analysis, the factors that favored both remission and its durability were persistent lower levels of proteinuria and female sex. Complete remission indicates an excellent long-term prognosis in patients with IMGN, but relapses are common and, in a small percentage, chronic renal insufficiency occurs. Thus, our data suggest that even this group of patients should be monitored on a regular basis. (C) 1999 by the National Kidney Foundation, Inc.